HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.

AbstractOBJECTIVE:
To determine whether autotransfusion of red blood cells (RBCs) salvaged during liver transplantation is associated with the recurrence of hepatocellular carcinoma (HCC).
BACKGROUND:
Blood salvage is widely used during liver transplantation to reinfuse salvaged autologous RBCs and reduce allogeneic transfusion. However, the reintroduction of cancer cells via autotransfusion is a major concern in HCC patients.
METHODS:
Among 397 patients who underwent living-donor liver transplantation for HCC, 97 of 114 recipients without intraoperative autotransfusion were matched with 222 of 283 recipients with intraoperative autotransfusion with unfixed matching ratio using the propensity score based on age, sex, allogeneic transfusion, immunosuppression, tumor biology, and others. Competing risks Cox regression was used to compare HCC recurrence risk of the 2 paired groups.
RESULTS:
Recipients in autotransfusion group received 1177ā€Š±ā€Š1318 mL of salvaged RBCs during surgery. A leukocyte depletion filter was used for all autotransfused RBCs. Cumulative HCC recurrence rate at 1, 2, and 5 years after transplantation were 10.4% (5.3%-17.6%), 19.1% (11.6%-28.0%), and 24.1% (15.2%-34.0%) for nonautotransfusion group and 10.8% (7.2%-15.4%), 14.9% (10.5%-20.0%), and 20.3% (14.9%-26.4%) for autotransfusion group, respectively. Autotransfusion versus nonautotransfusion group was not significantly different in overall recurrence [hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.47-1.53, Pā€Š=ā€Š0.579] and intrahepatic recurrence (HR 0.75, 95% CI 0.36-1.56) or extrahepatic recurrence (HR 1.00, 95% CI 0.49-2.04).
CONCLUSIONS:
We found no evidence of a significant impact of autotransfusion on posttransplant HCC recurrence. Thus, salvaged and filtered RBCs could be used in HCC patients undergoing liver transplantation with potential benefits from avoiding allogeneic RBCs transfusion and its complications.
AuthorsSangbin Han, Gaabsoo Kim, Justin S Ko, Dong Hyun Sinn, Ju Dong Yang, Jae-Won Joh, Suk-Koo Lee, Mi Sook Gwak
JournalAnnals of surgery (Ann Surg) Vol. 264 Issue 2 Pg. 339-43 (08 2016) ISSN: 1528-1140 [Electronic] United States
PMID26501715 (Publication Type: Journal Article)
Topics
  • Adult
  • Blood Transfusion, Autologous
  • Carcinoma, Hepatocellular (mortality, pathology, surgery)
  • Erythrocyte Transfusion
  • Female
  • Humans
  • Liver Neoplasms (mortality, pathology, surgery)
  • Liver Transplantation
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (epidemiology)
  • Operative Blood Salvage
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: